Search

Search Constraints

You searched for: Author/Creator Kramer, Daniel

Search Results

1. 2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3 – LBA: immunogenicity, biomarkers and PK assays). (December 2017)

2. A benchtop system to assess the feasibility of a fully independent and implantable brain-machine interface. (12th November 2019)

3. 2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 – LBA, biomarkers and immunogenicity). (November 2016)

4. Feedback from the European Bioanalysis Forum: focus workshop on current analysis of immunogenicity: best practices and regulatory hurdles. (February 2018)

5. Safety biomarkers for development of vaccines and biologics: Report from the safety biomarkers symposium held on November 28–29, 2017, Marcy l'Etoile, France. Issue 51 (3rd December 2020)

6. Cyclophosphamide and tucotuzumab (huKS-IL2) following first-line chemotherapy in responding patients with extensive-disease small-cell lung cancer. Issue 10 (November 2015)

7. Cyclophosphamide and tucotuzumab (huKS-IL2) following first-line chemotherapy in responding patients with extensive-disease small-cell lung cancer. Issue 10 (November 2015)

8. Challenges of non-clinical safety testing for biologics: A Report of the 9th BioSafe European Annual General Membership Meeting. Issue 1 (1st January 2021)